Data Waiver Team Phone Solution

In accordance with the terms of FAR 12.603: (i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. (ii) The solicitation number for this requirement is HHS-AMS-RFQ-22-75P00122Q00099 and this is a Request for Quote for the Substance Abuse and Mental Health Services Administration(SAMHSA)/Division of Pharmacologic Therapies (DPT). (iii) The solicitation document and incorporated provisions and clauses are those in effect Through Federal Acquisition Circular 2022-07. (iv) This acquisition is not a small business set-aside. The North American Industry Classification System (NAICS) Code for this acquisition is 541511, and the small-business size standards is $30 million. (v) All descriptions of services needed are included in the RFQ document attached. (vi) This is a Fixed Price requirement. Offeror should be aware that the Government will determine award based on a lowest price determination. (vii) The period of performance will be Base period and Option period 1. The following clauses apply to this acquisition: (viii) The provision at 52.212-1, Instructions to Offerors-Commercial, applies to this acquisition and a statement regarding any addenda to the provision. (ix) The provision at 52.212-2, Evaluation-Commercial Items, is applicable. The specific evaluation criteria in paragraph (v) are included within the attachment entitled SAMHSA Solicitation. (x) Offerors shall include a completed copy of the provision at 52.212-3, Offeror Representations and Certifications-Commercial Items, with its offer, or submit a printout to their Online Reps and Certs. (xi) The clause at 52.212-4, Contract Terms and Conditions-Commercial Items, applies to this acquisition. The clause, as well as any addenda to the clause, are included in the attachment entitled SAMHSA Solicitation. (xii) The clause at 52.212-5, Contract Terms and Conditions Required To Implement Statutes or Executive Orders-Commercial Items, applies to this acquisition. Applicable clauses can be found in the attachment entitled SAMHSA Solicitation. (xiii) Any additional contract requirement(s) or terms and conditions (such as contract financing arrangements or warranty requirements) determined by the contracting officer to be necessary for this acquisition and consistent with customary commercial practices can be found in the attachment entitled "Provisions for Commercial Items". There is no Defense Priorities and Allocations System (DPAS) rating assigned to this acquisition. (xiv) In order to be considered for an award, an offeror must have completed the online electronic Representations and Certifications located at https://www.sam.gov in accordance with FAR 4.1201(a). By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in SAM at https://www.sam.gov/ prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation [Note: Lack of registration in the System for Award Management will make an offeror ineligible for award.] All responsible sources may submit an offer that will be considered by the Agency. (xv) Place of Delivery Address: Department of Health and Human Services 7700 Wisconsin Ave. Bethesda, MD 20857 (xvi) Offers must be submitted on September 1, 2022. E-mail submissions to Shirlene.Smith@psc.hhs.gov by required response time. Fax submissions are not authorized. Requests for further information or questions concerning this requirement must be submitted in writing to Shirlene.Smith@psc.hhs.gov by August 29, 2022. (xvii) Point of Contact Shirlene Smith, Contract Specialist Phone: 240-781-3899 Email: Shirlene.Smith@psc.hhs.gov